These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 14997127)

  • 1. Endoscopic ligation vs. nadolol in the prevention of first variceal bleeding in patients with cirrhosis.
    Lo GH; Chen WC; Chen MH; Lin CP; Lo CC; Hsu PI; Cheng JS; Lai KH
    Gastrointest Endosc; 2004 Mar; 59(3):333-8. PubMed ID: 14997127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of endoscopic variceal ligation and nadolol plus isosorbide-5-mononitrate in the prevention of first variceal bleeding in cirrhotic patients.
    Wang HM; Lo GH; Chen WC; Tsai WL; Chan HH; Cheng LC; Hsu PI; Lai KH
    J Chin Med Assoc; 2006 Oct; 69(10):453-60. PubMed ID: 17098669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled trial of ligation plus nadolol versus nadolol alone for the prevention of first variceal bleeding.
    Lo GH; Chen WC; Wang HM; Lee CC
    Hepatology; 2010 Jul; 52(1):230-7. PubMed ID: 20578138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esophageal variceal ligation for acute variceal bleeding: results of three years' follow-up.
    Altintaş E; Sezgin O; Kaçar S; Tunç B; Parlak E; Altiparmak E; Saritaş U
    Turk J Gastroenterol; 2004 Mar; 15(1):27-33. PubMed ID: 15264118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding.
    Villanueva C; Miñana J; Ortiz J; Gallego A; Soriano G; Torras X; Sáinz S; Boadas J; Cussó X; Guarner C; Balanzó J
    N Engl J Med; 2001 Aug; 345(9):647-55. PubMed ID: 11547718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Banding ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding.
    Lo GH; Chen WC; Chen MH; Hsu PI; Lin CK; Tsai WL; Lai KH
    Gastroenterology; 2002 Sep; 123(3):728-34. PubMed ID: 12198699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial.
    de la Peña J; Brullet E; Sanchez-Hernández E; Rivero M; Vergara M; Martin-Lorente JL; Garcia Suárez C
    Hepatology; 2005 Mar; 41(3):572-8. PubMed ID: 15726659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of endoscopic variceal ligation (EVL) versus propanolol plus isosorbide mononitrate/nadolol (ISMN) in the prevention of variceal rebleeding: comparison of cirrhotic and noncirrhotic patients.
    Sarin SK; Wadhawan M; Gupta R; Shahi H
    Dig Dis Sci; 2005 Aug; 50(8):1538-47. PubMed ID: 16110851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial.
    Lo GH; Lai KH; Cheng JS; Chen MH; Huang HC; Hsu PI; Lin CK
    Hepatology; 2000 Sep; 32(3):461-5. PubMed ID: 10960435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Gruppo-Triveneto per L'ipertensione portale (GTIP).
    Merkel C; Marin R; Enzo E; Donada C; Cavallarin G; Torboli P; Amodio P; Sebastianelli G; Sacerdoti D; Felder M; Mazzaro C; Beltrame P; Gatta A
    Lancet; 1996 Dec 21-28; 348(9043):1677-81. PubMed ID: 8973428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, controlled trial of carvedilol versus nadolol plus isosorbide mononitrate for the prevention of variceal rebleeding.
    Lo GH; Chen WC; Wang HM; Yu HC
    J Gastroenterol Hepatol; 2012 Nov; 27(11):1681-7. PubMed ID: 22849337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study between nadolol and 5-isosorbide mononitrate vs. endoscopic band ligation plus sclerotherapy in the prevention of variceal rebleeding in cirrhotic patients: a randomized controlled trial.
    Romero G; Kravetz D; Argonz J; Vulcano C; Suarez A; Fassio E; Dominguez N; Bosco A; Muñoz A; Salgado P; Terg R
    Aliment Pharmacol Ther; 2006 Aug; 24(4):601-11. PubMed ID: 16827811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Argon plasma coagulation prevents variceal recurrence after band ligation of esophageal varices: preliminary results of a prospective randomized trial.
    Cipolletta L; Bianco MA; Rotondano G; Marmo R; Meucci C; Piscopo R
    Gastrointest Endosc; 2002 Oct; 56(4):467-71. PubMed ID: 12297759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved survival in patients receiving medical therapy as compared with banding ligation for the prevention of esophageal variceal rebleeding.
    Lo GH; Chen WC; Lin CK; Tsai WL; Chan HH; Chen TA; Yu HC; Hsu PI; Lai KH
    Hepatology; 2008 Aug; 48(2):580-7. PubMed ID: 18666235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trial: a randomized controlled study on prevention of variceal rebleeding comparing nadolol + ligation vs. hepatic venous pressure gradient-guided pharmacological therapy.
    Villanueva C; Aracil C; Colomo A; Lopez-Balaguer JM; Piqueras M; Gonzalez B; Torras X; Guarner C; Balanzo J
    Aliment Pharmacol Ther; 2009 Feb; 29(4):397-408. PubMed ID: 19006538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic banding ligation of high-risk esophageal varices in patients with cirrhosis: a prospective, randomized trial.
    Lo GH; Lai KH; Cheng JS; Lin CK; Hsu PI; Chiang HT
    J Hepatol; 1999 Sep; 31(3):451-6. PubMed ID: 10488703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis.
    Merkel C; Marin R; Sacerdoti D; Donada C; Cavallarin G; Torboli P; Amodio P; Sebastianelli G; Bolognesi M; Felder M; Mazzaro C; Gatta A
    Hepatology; 2000 Feb; 31(2):324-9. PubMed ID: 10655253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic indicators of successful endoscopic sclerotherapy for prevention of rebleeding from oesophageal varices in cirrhosis: a long-term cohort study.
    Madonia S; D'Amico G; Traina M; Gatto G; Virdone R; Salamone N; Licata A; Tarantino I; Pagliaro L
    Dig Liver Dis; 2000 Dec; 32(9):782-91. PubMed ID: 11215559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of endoscopic variceal sclerotherapy with sequential endoscopic band ligation plus low-dose sclerotherapy for secondary prophylaxis of variceal hemorrhage: a prospective randomized study.
    Garg PK; Joshi YK; Tandon RK
    Gastrointest Endosc; 1999 Sep; 50(3):369-73. PubMed ID: 10462658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic variceal ligation vs. propranolol for prevention of first variceal bleeding: a randomized controlled trial.
    Psilopoulos D; Galanis P; Goulas S; Papanikolaou IS; Elefsiniotis I; Liatsos C; Sparos L; Mavrogiannis C
    Eur J Gastroenterol Hepatol; 2005 Oct; 17(10):1111-7. PubMed ID: 16148558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.